Rabeprazole 20 mg & Itopride 150 mg (Sustained Release) About
Rabeprazole 20 mg & Itopride 150 mg (Sustained Release) is a potent combination medicine designed to treat moderate to severe or unresponsive GERD (Gastroesophageal Reflux Disease) and reflux esophagitis. Available in capsule and tablet form, this dual-action formula targets gastric issues effectively. Rabeprazole 20 mg works as a proton pump inhibitor, reducing gastric acid production, while Itopride 150 mg improves gastrointestinal motility for enhanced digestive performance. Suitable for daily consumption, the recommended dosage is one capsule or tablet per day. Specifically formulated for individuals with persistent or chronic gastric conditions, this general medicine combination is highly effective for managing reflux and digestive discomfort. Ideal for export, manufacturing, and supply purposes, it is tailored for therapeutic use in clinical or commercial environments.